Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-11-08

FDA Approved: CLEVIPREX — Supplemental Application (Fresenius Kabi Austria GmbH)

View source ↗

Summary

The FDA approved a supplemental application for CLEVIPREX (clevidipine), submitted by Fresenius Kabi Austria GmbH. The action is categorized as an approved supp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLEVIPREX (clevidipine)

Snippet

SUPPL AP for CLEVIPREX (CLEVIDIPINE)